DK125789B -
Analogous process for the preparation of racemic or optically active 9,10-dihydro-9,10-ethanoanthracenes or acid addition salts thereof.
- Google Patents
Analogous process for the preparation of racemic or optically active 9,10-dihydro-9,10-ethanoanthracenes or acid addition salts thereof.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1269Aexternal-prioritypatent/CH507904A/en
Priority claimed from CH1795169Aexternal-prioritypatent/CH530366A/en
Application filed by Ciba Geigy AgfiledCriticalCiba Geigy Ag
Publication of DK125789BpublicationCriticalpatent/DK125789B/en
A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
A47C—CHAIRS; SOFAS; BEDS
A47C3/00—Chairs characterised by structural features; Chairs or stools with rotatable or vertically-adjustable seats
A47C3/18—Chairs or stools with rotatable seat
DK570A1969-01-031970-01-02
Analogous process for the preparation of racemic or optically active 9,10-dihydro-9,10-ethanoanthracenes or acid addition salts thereof.
DK125789B
(en)
Analogous process for the preparation of 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives or acid addition salts thereof or the corresponding optically active compounds.
Analogous process for the preparation of racemic or optically active substituted 3-alkoxythianaphthen-2-carboxamides or acid addition salts or quaternary ammonium salts thereof.
Analogous process for the preparation of racemic or optically active 1- (2-nitrilophenoxy) -2-hydroxy-3-ethylaminopropane or acid addition salts thereof.
Analogous process for the preparation of racemic or optically active 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes or their physiologically acceptable acid addition salts.
Analogous process for the preparation of racemic or optically active 3,5-disubstituted phenylethanolamine compounds or therapeutically acceptable acid addition salts thereof.